Schrodinger, Inc. Price to Sales Ratio 2019-2024 | SDGR
Historical PS ratio values for Schrodinger, Inc. (SDGR) over the last 10 years. The current P/S ratio for Schrodinger, Inc. as of February 21, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Schrodinger, Inc. P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-02-21 | 22.64 | 8.61 | |
| 2024-09-30 | 18.55 | $2.63 | 7.05 |
| 2024-06-30 | 19.34 | $2.74 | 7.06 |
| 2024-03-31 | 27.00 | $2.56 | 10.57 |
| 2023-12-31 | 35.80 | $2.93 | 12.23 |
| 2023-09-30 | 28.27 | $2.74 | 10.33 |
| 2023-06-30 | 49.92 | $2.66 | 18.74 |
| 2023-03-31 | 26.33 | $2.74 | 9.62 |
| 2022-12-31 | 18.69 | $2.54 | 7.35 |
| 2022-09-30 | 24.98 | $2.40 | 10.41 |
| 2022-06-30 | 26.41 | $2.30 | 11.48 |
| 2022-03-31 | 34.12 | $2.18 | 15.63 |
| 2021-12-31 | 34.83 | $1.96 | 17.81 |
| 2021-09-30 | 54.68 | $1.85 | 29.52 |
| 2021-06-30 | 75.61 | $1.79 | 42.34 |
| 2021-03-31 | 76.29 | $1.73 | 44.14 |
| 2020-12-31 | 79.18 | $1.91 | 41.38 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $1.650B | $0.217B |
| Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK. | |||